Legal Representation
Attorney
Frances M. Jagla
USPTO Deadlines
Next Deadline
116 days remaining
NOA E-Mailed - SOU Required
Due Date
May 07, 2026
Extension Available
Until November 07, 2026
Application History
43 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 28, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 27, 2025 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Oct 27, 2025 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Oct 27, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 19, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 18, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Apr 18, 2025 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Apr 18, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 21, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 21, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Oct 21, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Oct 21, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 15, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 14, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 14, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 14, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 7, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 24, 2023 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | Loading... |
| May 31, 2023 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
| May 16, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 16, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 26, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 13, 2023 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Apr 12, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 12, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Apr 12, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 12, 2023 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 12, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Mar 9, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 9, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 9, 2023 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Sep 29, 2022 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Sep 29, 2022 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Sep 29, 2022 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Sep 8, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 7, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 7, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 11, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 11, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 11, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 10, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 1, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 13, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for treating rare diseases, metabolic diseases, and neurodegenerative diseases
Class 042
Scientific and medical research
Class 044
Providing information relating to medical disorders, diagnosis and treatment options, not including addiction treatment, substance abuse, cognitive therapy, psychological counseling or psychotherapy
Classification
International Classes
005
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"